Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL), a global leader in supplemental insurance, provides critical financial protection through innovative products in the U.S. and Japan. This news hub offers investors and stakeholders centralized access to verified corporate developments, strategic initiatives, and market updates.
Track official announcements, product launches, and leadership changes alongside analyses of Aflac's voluntary benefits expansion and technology partnerships. Our curated collection includes earnings reports, regulatory filings, and coverage of community-focused programs like pediatric cancer research support.
Discover updates on Aflac's core insurance offerings including accident, dental, and cancer coverage innovations. Stay informed about operational milestones in both the Japanese and American markets through primary-source documents and contextual reporting.
Bookmark this page for real-time updates on AFL's financial performance, dividend declarations, and industry leadership in supplemental health solutions. Verify all information through direct links to SEC filings and company-issued communications.
Aflac Global Investments (AGI), a subsidiary of Aflac, announced its plan to acquire a 40% stake in Tree Line Capital Partners, a San Francisco-based lower middle-market direct lender. Alongside this acquisition, Aflac is also committing a portion of its annual investable cash flow to Tree Line over several years. Tree Line, managing $2.7 billion in assets and founded by Tom Quimby and Jon Schroeder, will maintain its autonomy and leadership. This partnership aligns with Aflac's growth strategy, specifically enhancing its capabilities in middle-market direct lending. The deal is expected to accelerate Tree Line's growth and expand its offerings.
Aflac's My Special Aflac Duck(R) has been proven effective in helping children cope with cancer, as shown in recent clinical research. The robotic duck reduces distress, nausea, pain, and anxiety associated with cancer treatments, benefiting both pediatric cancer patients and caregivers. The unexpected positive findings from the study highlight the valuable contribution of the duck in supporting the entire children's ecosystem. More than 29,000 ducks have been distributed free of charge to children diagnosed with cancer and blood disorders, showcasing Aflac's commitment to children's health.
Aflac Incorporated reported strong first-quarter results with total revenues of $5.4 billion, net earnings of $1.9 billion, and a second-quarter cash dividend declared. Shareholders' equity increased to $23.5 billion with a return on equity of 33.0%. Aflac Japan saw net earned premiums decline in yen terms but increased profit margins. Aflac U.S. experienced growth in net earned premiums and adjusted net investment income. The board declared a dividend of $0.50 per share and $750 million was deployed to repurchase shares.
FAQ
What is the current stock price of Aflac (AFL)?
What is the market cap of Aflac (AFL)?
